SQZ Biotechnologies Co (SQZB) Share-based Payment Arrangement, Expense USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
SQZ Biotechnologies Co quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • SQZ Biotechnologies Co Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $983 K, a 58.6% decline year-over-year.
  • SQZ Biotechnologies Co Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $4.6 M, a 48.5% decline year-over-year.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2022 was $8.4 M, a 1.2% decline from 2021.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2021 was $8.51 M, a 136% increase from 2020.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2020 was $3.6 M, a 70.9% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $4.6 M $983 K -$1.39 M -58.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $6 M $1.15 M -$1.16 M -50.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $7.15 M $695 K -$1.25 M -64.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $8.4 M $1.77 M -$541 K -23.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-22
Q3 2022 $8.94 M $2.38 M -$405 K -14.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $9.35 M $2.31 M +$478 K +26.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $8.87 M $1.95 M +$366 K +23.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $8.51 M $2.31 M +$960 K +70.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $7.55 M $2.78 M +$1.99 M +249% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.56 M $1.83 M +$1.08 M +143% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $4.49 M $1.58 M +$883 K +127% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.6 M $1.35 M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 $796 K +$305 K +62.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $754 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $698 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $491 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.